Menu

Nuvation Bio Inc. NUVB

Full chart Compare
Set alert

Price alert · NUVB

All alert types
4.16 USD -0.03 (-0.72%)

At closeNov 6, 2026, 6:45 PM EST

4.19 +0.03 +0.72%

After hours · Nov 6, 6:45 PM ET

3.98 Day range 4.33
4.05 52-week range 9.54
YTD
-53.57%
1 year
-17.13%

Revenue & Expenses

Revenue by
Other Income → Expenses: $8.44MLicense → Revenue: $38.24MExpenses → Selling, General & Admin: $151.56MExpenses → Research & Development: $115.11MExpenses → Other Operating Expenses: $856.00KGross Profit → Expenses: $54.46MRevenue → Gross Profit: $54.46MRevenue → Cost of Revenue: $8.44MProduct → Revenue: $24.66MNet Loss → Expenses: $204.63MOther Income$8.44MGross Profit$54.46MNet Loss$204.63MCost of Revenue$8.44MExpenses$267.52MSelling, General & Admin$151.56MResearch & Development$115.11MOther Operating Expenses$856.00KRevenue$62.90MLicense$38.24MProduct$24.66M

Latest period ending Dec 31, 2025 · select a line to chart its full history

NUVB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
62.90M7.87M000
53.60M795.00K000
-213.06M-592.63M-99.82M-119.73M-93.32M
-204.63M-567.94M-75.80M-104.20M-86.85M
-0.60-2.11-0.35-0.48-0.44
NUVB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
164.09M35.72M42.65M101.10M132.42M
594.82M540.63M621.48M672.14M776.15M
289.11M76.84M16.36M17.07M30.15M
212.76M8.91M4.01M4.26M3.06M
305.72M463.79M605.12M655.08M746.00M
NUVB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-173.43M-130.41M-68.00M-96.11M-68.19M
99.52M122.70M8.92M63.46M-454.67M
202.53M331.00K628.00K1.33M625.53M
-354.00K-162.00K-55.00K-357.00K-282.00K
128.36M-6.93M-58.45M-31.32M102.67M